Atlas Trials

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes

Clinical trial NCT01924637 · COMPLETED

Trial details

NCT number
NCT01924637
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1
Start date
2013-08-01
Primary completion
2013-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.